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Abstract 
 
The reaction of 2-(2H-tetrazol-5-yl)pyridine (L1) with 1,6-dibromohexane results in formation of 
the isomers 2-(6′′-bromohexyl-(1-tetrazol-5-yl)pyridine (L2) and 2-(6′′-bromohexyl-(2-tetrazol-5-
yl)pyridine (L3). Coordination reactions of L2 and L3 with CuCl2·2H2O, Co(SCN)2 and 
Fe(ClO4)2·H2O yielded the strongly coloured solids [Cu(II)(L2)Cl2]2 (1), [Cu(II)(L3)Cl2]2 (2), 
[Co(II)(L2)2(NCS)2] (3), [Co(II)(L3)2(NCS)2] (4), [Fe(II)(L2)2(H2O)2](ClO4)2 (5) and 
[Fe(II)(L3)2(H2O)2](ClO4)2 (6), containing high-spin metal centres for the Co(II) and Fe(II) 
compounds. X-ray crystal structures were obtained for complexes 1–5. In each complex, ligands L2 
and L3 coordinate to the metal centre through the pyridyl N atom and the 1-N site of the tetrazole 
ring, and the pyridyl-tetrazole ligand remains planar in all cases except 3. Complexes 1 and 2 
comprise a central Cu2Cl2 dimeric core with Cu(II) in an essentially square-pyramidal coordination 
environment. Complexes 3 and 4 contain Co(II) in a distorted octahedral coordination environment. 
In 3, the pyridyl and tetrazole rings of L2 are twisted with respect to each other and the complex 
adopts a puckered conformation in its equatorial plane. Complex 5 contains water molecules 
coordinated to Fe(II) in the axial sites, which form hydrogen bonds to the perchlorate counter 
anions. 
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Introduction 
 
A great deal of attention has been devoted toward the synthesis of functional compounds containing 
polyazole rings, particularly tetrazoles and their derivatives, due to their practical applications.
1-4
 
The development of “click” chemistry, as described by Sharpless and co-workers,5 has resulted in a 
recent increase in tetrazole structures. Tetrazole derivatives have found applications in therapeutics 
as antihypertensive agents,
6
 antibiotics,
7
 and drugs for AIDS treatment.
8 
They are also studied in the 
field of coordination chemistry.
9
 Both tetrazole and its derivatives, normally the 5-substituted 
derivatives, can act as both di- and polydentate ligands exhibiting several coordination modes.
10
 
Mono 1- and 2-substituted tetrazoles are often used for the construction of coordination 
networks.
9,10
 Our interest in tetrazoles concerns their use as precursors for the formation of new 
functionalized polytetrazole macromolecules, which have potential applications as sensors or in 
molecular recognition. We have previously reported the addition of pendant short-chain arms to 
various bis-tetrazoles, as well as the synthesis of several tetra-tetrazole macrocycles, including the 
first example of a host-guest interaction between a tetra-tetrazole macrocycle and a solvent 
molecule.
11-16
 To expand this area, we are investigating the use of tetrazole containing compounds 
as potential metal-based therapeutic agents, especially as anti-cancer or anti-fungicidal agents. In 
this paper, we describe the synthesis of some pyridyl-tetrazole compounds containing bromohexyl 
pendant arms (see Scheme 1) and examine their coordination chemistry with Fe(II), Co(II) and 
Cu(II) salts, which are a range of metal cations which the human body can tolerate. The biological 
studies of these complexes will be discussed in a future paper.
17
  
 
Results and Discussion 
 
Ligand syntheses and characterisation 
 
Synthesis of 2-(2H-tetrazol-5-yl)pyridine (L1) and its subsequent reaction with 1,6-dibromoexane 
to give the isomers 2-(6’’-bromohexyl-(1-tetrazol-5-yl)pyridine (L2) and 2-(6’’-bromohexyl-(2-
tetrazol-5-yl)pyridine (L3) was carried out as in a manner similar to that described in the 
literature,
18
 as shown in Scheme 1. The reaction of sodium azide with 2-cyanopyridine in the 
presence of ammonium chloride and lithium chloride in dry dimethylformamide (DMF) yielded L1 
as brown needles on recrystallisation from ethanol. The 
13
C NMR and IR spectra of the needles 
confirmed the presence of the tetrazole ring with a signal at 154.9 ppm in the 
13
C NMR spectrum 
indicating the formation of a 1,5-disubstituted tetrazole and the absence of a signal at 2220 cm
-1
 in 
the IR spectrum due to an azide band.
15,19,20
 The 
1
H NMR spectrum of L1, obtained in CD3OD, 
4 
 
showed the expected signals for the pyridine ring, while the NH proton on the tetrazole appeared as 
a broad signal at 3.9 ppm. 
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Scheme 1 Reaction conditions: i) NaN3, LiCl, NH4Cl, DMF, Δ, 10 hr; ii) 1,6-dibromohexane, 
K2CO3, butanone, Δ, 24 hr; R = C6H12Br. 
 
The reaction of L1 with 1,6-dibromohexane in either 2-butanone or acetonitrile with potassium 
carbonate as base gave a mixture of products L2 and L3, arising from alkylation at either the 1-N or 
2-N positions. Column chromatography separated the products from the reactants. Both L2 and L3 
are low melting, waxy solids. The isomers are readily distinguishable by their 
13
C NMR spectra 
with the 
13
C NMR chemical shift of the tetrazole C atom appearing at ca. 154.0 or 164.0 ppm in the 
1,5- and 2,5-disubstituted tetrazoles, respectively.
15,19,20
 In this case, the 1-N isomer (L2) gave a 
signal at 151.4 ppm, while the 2-N isomer (L3) gave a signal at 164.7 ppm. The 
1
H NMR spectra of 
both L2 and L3 show four signals for the pyridyl protons, a triplet for methylene group beside the 
Br atom, a triplet for the methylene group beside the tetrazole and three other signals for the 
remaining methylene groups of the bromoalkyl chain. The signals for the methylene protons beside 
the tetrazole appear at 5.00 ppm for L2 and 4.73 ppm for L3. 
 
Coordination Reactions 
 
The transition-metal salts CuCl2.2H2O, Co(SCN)2 and Fe(ClO4)2.H2O were reacted with L2 and L3, 
respectively, in methanol at reflux temperature under an inert atmosphere for two hours. All 
reactions were carried out using a 1:1 metal:ligand stoichiometry (see Schemes 2 & 3). The 
resulting strongly coloured solutions were allowed to stand for several days, after which time the 
5 
 
solid products were filtered off. Elemental analyses on all of the products obtained showed that the 
Cu complexes (1 and 2) have a 1:1 metal:ligand composition while both the Co complexes (3 and 4) 
and the Fe complexes (5 and 6) had a 1:2 metal:ligand composition. 
 
The Cu complexes 1 and 2 have magnetic moments of 2.6 and 3.2 B.M., respectively, which 
indicate the expected presence of Cu(II). Both Co complexes 3 and 4 have magnetic moments in the 
ranges of 4.5 and 3.65 B.M., which are consistent with the presence of high-spin Co(II). The 
magnetic moments for the Fe complexes 5 and 6 are 4.7 and 5.0 B.M., respectively, which indicate 
the presence of high-spin Fe(II). The observation of high-spin ions in the latter two cases is 
consistent with the findings of Henderson et al. who have reported several Mn complexes of L1 all 
contained high-spin Mn(II).
9a
 
 
 
 
Scheme 2 Reaction conditions: i) CuCl2.2H2O, MeOH, Δ, 2 hr; ii) Co(SCN)2, MeOH, Δ, 2 hr; i) 
Fe(ClO4)2.xH2O, MeOH, Δ, 2 hr. 
6 
 
 
 
 
Scheme 3 Reaction conditions: i) CuCl2.2H2O, MeOH, Δ, 2 hr; ii) Co(SCN)2, MeOH, Δ, 2 hr; i) 
Fe(ClO4)2.xH2O, MeOH, Δ, 2 hr. 
 
Crystal structures of the Cu(II) complexes 1 and 2 
 
Dark green crystals of 1 and 2 suitable for X-ray diffraction were obtained from methanol and 
ethanol solutions of CuCl2.H2O with L2 and L3, respectively. Crystallographic data for all 
structures are presented in Table 1. Both 3 and 7 consist of dichloro-bridged dimeric {Cu(II)(μ-
Cl)Cl}2 units, with the coordination sphere about each Cu(II) atom comprising one pyridine N 
atom, one tetrazole N atom and three Cl atoms (Figs. 1 and 2). Selected bond distances and angles 
are listed in Tables 2 and 3, respectively. In 1, the complex lies on a crystallographic inversion 
centre, while in 2, the bromohexyl chains adopt different conformations with respect to the central 
core of the complex. One of the hexyl chains in 2 is disordered (Fig. 2). 
7 
 
 
 
 
Fig. 1 Molecular structure of 1 with displacement ellipsoids at the 50% probability level (H atoms 
omitted). The complex lies on a crystallographic inversion centre. 
 
 
 
Fig. 2 Molecular structure of 2 with displacement ellipsoids at the 50% probability level (H atoms 
omitted). One bromohexyl pendant arm is modelled as disordered over three orientations. 
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Table 1 Crystallographic Data for 1- 5. 
 1 2 3 4 5 
Formula C24H32Br2Cl4Cu2N10 C24H32Br2Cl4Cu2N10 C26H32Br2CoN12S2 C26H32Br2CoN12S2 C24H36Br2Cl2FeN10O10 
M/g mol
–1
 889.30 889.30 795.51 795.51 911.20 
Crystal system Triclinic Triclinic Triclinic Triclinic Monoclinic 
Space group P-1 P-1 P-1 P-1 P21/c 
T/K 180(2) 150(2) 120(2) 150(2) 150(2) 
a/Å 9.2946(5) 9.5645(17) 8.7827(4) 8.2324(15) 9.8682(11) 
b/Å 9.4441(7) 12.213(2) 12.1112(6) 12.863(2) 11.7061(12) 
c/Å 10.6132(7) 14.688(3) 16.0963(6) 15.951(3) 15.2784(16) 
α/° 76.945(2) 92.214(3) 83.204(2) 99.917(3) 90 
β/° 80.052(2) 107.256(2) 83.219(2) 93.901(3) 92.999(2) 
γ/° 66.114(2) 93.937(2) 74.195(2) 90.270(3) 90 
V/Å
3
 826.35(9) 1631.5(5) 1629.23(13) 1659.8(5) 1762.5(3) 
Z 1 2 2 2 2 
Dc/g cm
-3
 1.787 1.810 1.622 1.592 1.717 
Reflections collected 14734 13771 32290 12805 14802 
Unique reflections 2897 6383 6043 5600 3463 
Rint 0.026 0.050 0.033 0.067 0.041 
Observed reflections 2632 3783 4855 2764 2565 
[I > 2(I)]      
No. parameters 190 415 398 426 319 
No. restraints 0 147 0 468 218 
R1 [I > 2(I)] 0.0264 0.066 0.041 0.081 0.047 
wR2 (all data) 0.074 0.217 0.108 0.252 0.115 
GOF 1.09 1.03 1.04 1.05 1.05 
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The geometry of the central core is closely comparable in 1 and 2: the 28 non-H atoms in each 
complex (excluding the bromohexyl chains) can be overlaid with an rms deviation of 0.13 Å. The 
coordination geometry of each Cu(II) centre is distorted square pyramidal. The Addison parameter, 
t, is 0.19 for 1, compared to 0.05 for Cu(1) and 0.12 for Cu(2), respectively, in 2 (where t = 0 for 
ideal square-pyramidal and t = 1 for ideal trigonal-bipyramidal).
21
 Each pyridyl-tetrazole ligand 
binds to the Cu(II) atom through one tetrazole N atom at the 1-N site of the tetrazole ring and 
through the pyridyl N atom, to generate a five-membered chelate ring. The tetrazole ring is coplanar 
with the pyridyl ring. This coplanarity has been seen in other metal complexes containing pyridyl-
tetrazole ligands.
9,10
 In the central core, the four-membered Cu2Cl2 rings are planar in both cases, 
and the Cu(II)-Cl bond distances are comparable to those of other dichloro-bridged dimers in the 
literature.
22
 The Cu-Cl(apical) bond distances are longer than the Cu-Cl(equatorial) bond distances 
by ca 0.35 Å (Table 2). 
 
Table 2 Selected bond lengths (Å) and angles (º) for 1 
 
Cu(1)-Cl(1) 2.2553(7) Cu(1)-N(4) 1.987(2) 
Cu(1)-Cl(1)
#1
 2.6392(8) Cu(1)-N(5) 2.088(2) 
Cu(1)-Cl(2) 2.2257(8)   
    
Cl(1)-Cu(1)-Cl(2) 94.32(3) N(4)-Cu(1)-Cl(1) 172.29(7) 
Cu(1)-Cl(1)-Cu(1)
#1
 89.97(2) N(4)-Cu(1)-Cl(2) 92.38(7) 
Cl(2)-Cu(1)-Cl(1)
#1
 106.12(3) N(4)-Cu(1)-Cl(1)
#1
 91.82(7) 
N(5)-Cu(1)-Cl(1) 94.28(6) N(4)-Cu(1)-N(5) 78.19(9) 
N(5)-Cu(1)-Cl(2) 160.64(7) Cl(1)-Cu(1)-Cl(1)
#1
 90.03(2) 
N(5)-Cu(1)-Cl(1)#1 91.20(6)   
Symmetry code #1: 2–x,–y,–z 
 
In 1, the two bromohexyl arms orient themselves above and below the central Cu2Cl2 core, pointing 
away from each other in a centrosymmetric arrangement (Fig. 1), whereas in 2, both arms point in 
the same direction (Fig. 2). This difference in orientation is probably attributable to packing effects. 
In 1, the complexes are arranged into well-defined layers, with the pyridyl ring of one L2 ligand 
approaching the tetrazole ring of an adjacent L2 ligand in a side-on co-planar fashion, making C–
H···N contacts (see Figures in ESI
†
). The bromohexyl arms form an interdigitated arrangement 
between those layers, with adjacent arms lying parallel to each other in a manner typical of close-
packed alkyl chains. In 2, the comparable side-on approach of L3 ligands is blocked by the presence 
of the bromohexyl arm, and the complexes instead adopt a bilayer type arrangement, where the 
pyridyl ring of one L3 ligand approaches the Cl atoms of an adjacent complex, making C–H···Cl 
10 
 
contacts. In this arrangement, the bromohexyl pendant arms are forced to lie on the same side of the 
complex, where they form a less well-defined packing pattern between the bilayers. 
 
Table 3 Selected bond lengths (Å) and angles (º) for 2 
 
Cu(1)-Cl(3) 2.235(2) Cu(2)-Cl(4) 2.229(2) 
Cu(1)-Cl(1) 2.716(2) Cu(2)-Cl(2) 2.671(2) 
Cu(1)-Cl(2) 2.2637(19) Cu(2)-Cl(1) 2.3178(18) 
Cu(1)-N(4A) 2.012(6) Cu(2)-N(4B) 2.013(6) 
Cu(1)-N(5A) 2.085(6) Cu(2)-N(5B) 2.090(6) 
    
Cl(3)-Cu(1)-Cl(2) 93.87(8) Cl(4)-Cu(2)-Cl(1) 94.10(7) 
Cl(2)-Cu(1)-Cl(1) 92.36(7) Cl(1)-Cu(2)-Cl(2) 92.30(7) 
Cl(3)-Cu(1)-Cl(1) 101.41(8) Cl(4)-Cu(2)-Cl(2) 104.93(8) 
N(4A)-Cu(1)-Cl(3) 91.79(19) N(4B)-Cu(2)-Cl(4) 90.89(18) 
N(4A)-Cu(1)-Cl(2) 167.9(2) N(4B)-Cu(2)-Cl(1) 169.71(19) 
N(4A)-Cu(1)-Cl(1) 97.0(2) N(4B)-Cu(2)-Cl(2) 95.09(19) 
N(4A)-Cu(1)-N(5A) 78.5(2) N(4B)-Cu(2)-N(5B) 78.5(2) 
N(5A)-Cu(1)-Cl(1) 91.24(19) N(5B)-Cu(2)-Cl(1) 94.41(17) 
N(5A)-Cu(1)-Cl(2) 93.66(18) N(5B)-Cu(2)-Cl(2) 90.10(19) 
N(5A)-Cu(1)-Cl(3) 165.0(2) N(5B)-Cu(2)-Cl(4) 162.39(19) 
Cu(2)-Cl(1)-Cu(1) 86.57(6) Cu(1)-Cl(2)-Cu(2) 88.75(7) 
 
Crystal structures of the Co(II) complexes 3 and 4 
 
Rust-coloured crystals of 3 were obtained from a methanol solution while green crystals of 4 were 
recrystallised from ethanol. Complex 3 contains one independent molecule lying on a 
crystallographic inversion centre, while 4 contains two independent complexes, lying on distinct 
crystallographic inversion centres. Selected bond distances and angles for 3 and 4 are listed in 
Tables 4 and 5, respectively. 
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Fig. 3 Molecular structure of 3 with displacement ellipsoids at the 50% probability level (H atoms 
omitted). One bromohexyl pendant arm displays disorder. 
 
 
 
Fig. 4 Molecular structure of 4 with displacement ellipsoids at the 50% probability level (H atoms 
omitted). Two independent complexes lie on crystallographic inversion centres. Both display 
disorder of the bromohexyl pendant arms. 
 
Table 4 Selected bond lengths (Å) and angles (º) for 3 
 
Co(1)-N(4) 2.142(3) Co(1)-N(4A) 2.122(3) 
Co(1)-N(5) 2.139(3) Co(1)-N(5A) 2.144(3) 
Co(1)-N(6) 2.039(3) Co(1)-N(6A) 2.082(3) 
    
N(6)-Co(1)-N(6A) 178.22(13) N(6)-Co(1)-N(4A) 94.33(12) 
N(6A)-Co(1)-N(4A) 87.44(12) N(6)-Co(1)-N(5) 90.03(12) 
N(6A)-Co(1)-N(5) 89.80(12) N(4A)-Co(1)-N(5) 103.13(12) 
12 
 
N(6)-Co(1)-N(4) 93.09(12) N(6A)-Co(1)-N(4) 85.14(12) 
N(4A)-Co(1)-N(4) 172.57(12) N(5)-Co(1)-N(4) 76.56(12) 
N(6)-Co(1)-N(5A) 91.55(12) N(6A)-Co(1)-N(5A) 88.62(12) 
N(4A)-Co(1)-N(5A) 76.73(11) N(5)-Co(1)-N(5A) 178.41(12) 
N(4)-Co(1)-N(5A) 103.37(11)   
 
Table 5 Selected bond lengths (Å) and angles (º) for 4 
 
Co(1A)-N(6A) 2.080(7) Co(1B)-N(6B) 2.061(9) 
Co(1A)-N(4A) 2.142(6) Co(1B)-N(4B) 2.137(7) 
Co(1A)-N(5A) 2.158(6) Co(1B)-N(5B) 2.156(6) 
    
N(6A)-Co(1A)-N(4A) 92.4(3) N(6B)-Co(1B)-N(4B) 88.6(3) 
N(6A)
#1
-Co(1A)-N(4A) 87.6(3) N(6B)-Co(1B)-N(4B)
#2
 91.4(3) 
N(6A)-Co(1A)-N(5A) 92.1(2) N(6B)
#2
-Co(1B)-N(5B) 87.4(3) 
N(6A)-Co(1A)-N(5A)
#1
 87.9(2) N(6B)-Co(1B)-N(5B) 92.6(3) 
N(4A)-Co(1A)-N(5A) 76.7(2) N(4B)
#2
-Co(1B)-N(5B) 102.8(2) 
N(4A)-Co(1A)-N(5A)
#1
 103.3(2) N(4B)-Co(1B)-N(5B)
#2
 77.2(2) 
Symmetry code #1: –x,–y,–z, #2: 1–x,–y,1–z. 
 
In both 3 and 4, Co(II) exhibits an octahedral coordination geometry with the equatorial plane 
consisting of two pyridyl-tetrazole ligands and the thiocyanate ligands in the axial positions. Again, 
each pyridyl-tetrazole ligand chelates to Co(II) through one tetrazole N atom at the 1-N site and 
through the pyridyl N atom. As for 1 and 2, the tetrazole rings are coplanar with the pyridine rings 
in 4, and the two pyridyl-tetrazole ligands within the complex are also approximately co-planar with 
each other. In 3, however, there is a significant twist within the ligand so that the planes of the 
tetrazole and pyridine rings form dihedral angles of 8.9(1) and 16.2(1)° in the two independent 
ligands, and the complex as a whole displays a much more puckered geometry (Fig. 3), reminiscent 
of the saddle conformation frequently observed in porphyrin complexes. Again, this appears to 
driven by packing effects. The complexes lie in layers where the equatorial planes of the complexes 
are all essentially parallel (as opposed to edge-to-face type contacts observed in 4) (Fig. 5). At one 
side of the complex, the pyridyl-tetrazole ligands with the smaller degree of twist meet in 
centrosymmetric face-to-face type contacts. At the other side of the complex, a bromohexyl chain 
lies across the face of an adjacent complex, and the tetrazole ring of the ligand is twisted away from 
that chain, giving rise to the larger twist within the ligand. The twist also introduces relatively short 
N···S contacts to a neighbouring thiocyanate ligand (3.325(4) Å). 
 
13 
 
 
 
Fig. 5 Neighbouring complexes in the crystal structure of 3. In the centre, the face-to-face 
interaction between pyridyl-tetrazole ligands with the smaller degree of twist is visible. On the left 
and right sides, the tetrazole rings are twisted away from the planes of the pyridyl rings in order to 
accommodate the neighbouring bromohexyl chains. 
 
X-Ray Analysis of the Fe(II) complex of L2 
 
Brown crystals of 5 were obtained from the reaction between Fe(ClO4)2.H2O and L2. Selected bond 
lengths and angles for 5 are given in Table 6. The complex lies on a crystallographic inversion 
centre and the bromoalkyl chain is modelled as disordered over two sets of positions (Fig. 6). The 
Fe(II) centre adopts a slightly distorted octahedral coordination geometry with the pyridyl-tetrazole 
ligands occupying the equatorial plane and water molecules occupying the axial positions. As for 1, 
2 and 4, the tetrazole ring is coplanar with the pyridine ring. The complexes lie in layers with the 
perchlorate counter anions (modelled as disordered) between layers accepting hydrogen bonds from 
the coordinated water molecules. 
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Fig. 6 Molecular structure of 5 with displacement ellipsoids at the 50% probability level (H atoms 
omitted). The complex lies on a crystallographic inversion centre. The bromohexyl chains and the 
perchlorate anions are modelled as disordered. 
 
Table 6 Selected bond lengths (Å) and angles (º) for 5 
Fe(1)-O(1W) 2.122(3) Fe(1)-N(5) 2.198(3) 
Fe(1)-N(4) 2.141(3) C(12)-Br(1) 1.947(4) 
    
O(1W)-Fe(1)-N(4) 88.10(11) O(1W)-Fe(1)-N(4)
#1
 91.90(11) 
O(1W)
#1
-Fe(1)-N(5) 89.46(10) O(1W)-Fe(1)-N(5) 90.54(10) 
N(4)-Fe-N(5) 75.03(11) N(4)
#1
-Fe(1)-N(5) 104.97(11) 
 
Experimental 
 
1
H and 
13
C NMR (δ ppm; J Hz) spectra were recorded on a JEOL JNM-LA300 FT-NMR 
spectrometer using saturated CDCl3 solutions with Me4Si reference, unless indicated otherwise, 
with resolutions of 0.18 Hz and 0.01 ppm, respectively. Infrared spectra (cm
-1
) were recorded as 
KBr discs or liquid films between KBr plates using either a Nicolet Impact 410 FT-IR spectrometer. 
Melting point analyses were carried out using a Stewart Scientific SMP 1 melting point apparatus 
and are uncorrected. Mass spectra were carried out in the Mass Spectrometry unit in the Centre for 
Synthesis and Chemical Biology, University College, Dublin. Magnetic susceptibility 
measurements were carried out at room temperature using a Johnson Matthey Magnetic 
Susceptibility Balance with [HgCo(SCN)4] as reference. Microanalyses were carried out at the 
Microanalytical Laboratory of University College, Dublin. Standard Schlenk techniques were used 
throughout. Starting materials were commercially obtained and used without further purification. 
15 
 
Caution! Nitrogen-rich compounds such as tetrazole derivatives are used as components for 
explosive mixtures.
1
 In our laboratory, the reactions described were run on a few gram scale, and 
no problems were encountered. However, great caution should be exercised when heating or 
handling compounds of this type. Caution! Although not encountered in our experiments, 
perchlorate salts of metal ions are potentially explosive and should be manipulated with care and 
used only in small quantities. 
 
Synthesis of 2-(2H-tetrazol-5-yl)pyridine (L1) 
 
A suspension of 2-cyanopyridine (4.14 g, 40 mmol), sodium azide (5.72 g, 88 mmol), ammonium 
chloride (4.70 g, 88 mmol) and lithium chloride (1.20 g, 28 mmol) in anhydrous 
dimethylformamide (40 mL) was stirred for 10 hours at 110 °C. After this time, the solution was 
cooled and the insoluble salts were removed by filtration. The solvent was then evaporated under 
reduced pressure and the residue was dissolved in deionised water (200 mL) and acidified with 
concentrated HCl (3 mL), to initiate precipitation. The product was removed by filtration, washed 
with water (3  40 mL) and dried to give a brown solid. This was recrystallised from hot ethanol to 
afford L1 as brown needles (3 g, yield 51.3 %). m.p. 221-223 °C. C6H5N5 (147.14): calcd. C 48.98, 
H 3.42, N 47.60; found C 48.97, H 3.44, N 47.61. 
1
H NMR (CD3OD): δ = 8.76 (d, 1 H, J = 7.9 Hz, 
pyr-H), 8.25 (d, 1 H, J = 7.9 Hz, pyr-H), 8.03 (t, 1 H, J = 7.9 Hz, pyr-H), 7.56 (t, 1 H, J = 7.9 Hz, 
pyr-H), 3.9 (s, 1 H, tet-H) ppm. 
13
C NMR (CD3OD): δ = 154.9 (CN4), 150.1, 143.7, 138.3, 126.2, 
122.7 ppm. ESI-HRMS: calcd for C6H5N5 [M]
+
 147.054, found 147.054. 
 
Synthesis of 2-(6’’-bromoalkyl-(1-tetrazol-5-yl)pyridine (L2) and 2-(6’’-bromoalkyl-(2-tetrazol-5-
yl)pyridine (L3) 
 
To L1 (1 g, 6.8 mmol) dissolved in either acetonitrile or 2-butanone (30 mL) was added potassium 
carbonate (9.38 g, 68 mmol). The resulting solution was refluxed for 30 minutes and to the hot 
solution was added 1,6-dibromohexane (4.97 g, 24 mmol). The reaction mixture was then stirred at 
reflux temperature for a further 24 h. After cooling, the solvent was removed under reduced 
pressure to afford an oil, which was purified by column chromatography on silica gel (initially at a 
ratio of petroleum ether : ethyl acetate 80:20, followed by the ratio of 60:40). This gave the 
products L2 and L3. 
 
L2: Waxy white solid (0.55 g, yield 26 %). m.p. 39-41 °C. C12H16N5Br (310.19): calcd. C 46.46, H 
5.20, N 22.58; found C 46.50, H 5.17, N 22.62. 
1
H NMR (CDCl3): δ = 8.77 (d, 1 H, J = 7.5 Hz, pyr-
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H), 8.37 (d, 1 H, J = 7.5 Hz, pyr-H), 7.96 (t, 1 H, J = 7.5 Hz, pyr-H), 7.52 (t, 1 H, J = 7.5 Hz, pyr-
H), 5.00 (t, 2 H, J = 6.9 Hz, CH2N), 3.42 (t, 2 H, J = 6.9 Hz, CH2Br), 2.02 (q, 2 H, J = 7.1 Hz, 
CH2), 1.87 (m, 2 H, CH2), 1.48 (m, 4 H, CH2) ppm. 
13
C NMR (CDCl3): δ = 151.4 (CN4), 149.3, 
144.6, 137.1, 125.1, 124.2, 49.2 (CH2N), 33.5 (CH2Br), 32.3, 32.1, 29.4, 27.2 ppm. ESI-HRMS: 
calcd for C12H17BrN5 [M+1]
+
 310.067, found 310.068. 
 
L3: Waxy white solid (0.35 g, yield 17 %). m.p. 36-38 °C. C12H16N5Br (310.19): calcd. C 46.46, H 
5.20, N 22.58; found C 46.44, H 5.17, N 22.63. 
1
H NMR (CDCl3): δ = 8.80 (d, 1 H, J = 7.7 Hz, pyr-
H), 8.27 (d, 1 H, J = 7.7 Hz, pyr-H), 7.90 (t, 1 H, J = 7.7 Hz, pyr-H), 7.43 (t, 1 H, J = 7.7 Hz, pyr-
H), 4.73 (t, 2 H, J = 6.8 Hz, CH2N), 3.39 (t, 2 H, J = 6.8 Hz, CH2Br), 2.13 (q, 2 H, J = 6.8 Hz, 
CH2), 1.83 (m, 2 H, CH2), 1.51 (m, 4 H, CH2) ppm. 
13
C NMR (CDCl3): δ = 164.7 (CN4), 150.2, 
146.7, 137.1, 124.8, 122.3, 53.2 (CH2N), 33.4 (CH2Br), 32.4, 32.2, 29.0, 27.3 ppm. ESI-HRMS: 
calcd for C12H17BrN5 [M+1]
+
 310.067, found 310.066. 
 
General coordination reactions (1-6) 
 
The appropriate tetrazole ligand, L2 or L3 (0.20 g, 1.36 mmol), was dissolved in methanol (30 mL) 
and was added to a solution of the appropriate metal salt (1.36 mmol) in methanol (25 mL). The 
resulting strongly-coloured solution was then heated to reflux for 2 h before being allowed to stand 
at room temperature for several days. 
 
[Cu(L2)Cl2]2 (1) 
 
Dark green crystals (0.137 g, yield 49%). C24H32Br2Cl4Cu2N10 (889.29): calcd. C 32.41, H 3.63, N 
15.75; found C 32.52, H 3.71, N 15.73. IR (KBr): υ = 2923, 2852, 1648, 1610, 1482, 1256, 1167, 
1139, 1019, 803, 723 cm
-1
. λmax (CH3CN) 832 nm, ε = 93 M
−1
cm
−1
. Magnetic moment: 2.6 B.M. 
 
[Cu(L3)Cl2]2 (2) 
 
Dark green crystals (0.14 g, yield 50%). C24H32Br2Cl4Cu2N10 (889.29): calcd. C 32.41, H 3.63, N 
15.75; found C 32.42, H 3.51, N 15.78. IR (KBr): υ = 2923, 2856, 1648, 1610, 1483, 1278, 1165, 
1019, 803, 721 cm
-1
. λmax (CH3CN) 812 nm, ε = 55 M
−1
cm
−1
. Magnetic moment: 3.2 B.M. 
 
Co(L2)2(NCS)2 (3) 
 
17 
 
Rust coloured crystals (0.130 g, yield 26%). C26H32Br2CoN12S2 (795.48): calcd. C 39.26, H 4.05, N 
21.13; found C 39.31, H 4.09, N 21.18. IR (KBr): υ = 2933, 2861, 2075, 1648, 1473, 1368, 1247, 
1159, 1105, 1047, 795, 728 cm
-1
. λmax (CH3CN) 512 nm, ε = 37 M
−1
cm
−1
. Magnetic moment: 4.5 
B.M. 
 
Co(L3)2(NCS)2 (4) 
 
Green crystals (0.146 g, yield 29%). C26H32Br2CoN12S2 (795.48): calcd. C 39.26, H 4.05, N 21.13; 
found C 39.65, H 4.19, N 20.86. IR (KBr): υ = 2928, 2858, 2075, 1654, 1474, 1368, 1247, 1159, 
1105, 1047, 796, 728 cm
-1
. λmax (CH3CN) 512 nm, ε = 45 M
−1
cm
−1
. Magnetic moment: 3.65 B.M. 
 
[Fe(L2)2(H2O)2](ClO4)2 (5) 
 
Yellow crystals (0.09 g, yield 16%). C24H36Br2Cl2FeN10O10 (911.16): calcd. C 31.64, H 3.98, N 
15.37; found C 31.62, H 3.91, N 15.41. IR (KBr): υ = 3407, 2924, 2852, 1637, 1478, 1379, 1250, 
1143, 1112, 798, 727 cm
-1
. λmax (CH3CN) 364 nm, ε = 1718 M
−1
cm
−1
. Magnetic moment: 4.7 B.M. 
 
[Fe(L3)2(H2O)2](ClO4)2 (6) 
 
Yellow solid (0.11 g, yield 20%). C24H36Br2Cl2FeN10O10 (911.16): calcd. C 31.64, H 3.98, N 15.37; 
found C 31.59, H 3.98, N 15.48. IR (KBr): υ = 3410, 2942, 2862, 1638, 1451, 1384, 1145, 1117, 
1089, 731 cm
-1
. λmax (CH3CN) 348 nm, ε = 219 M
−1
cm
−1
. Magnetic moment: 5.0 B.M. To date, we 
have not been able to obtain crystals of 6 suitable for X-ray diffraction analysis. 
 
Crystallography 
 
X-ray diffraction data were collected on a Bruker APEX-II CCD diffractometer using graphite-
monochromated Mo-Kα radiation ( = 0.7107 Å). In each case, a multi-scan correction was applied 
and the structures were refined against F
2
 using all reflections.
23
 All non-H atoms were refined with 
anisotropic atomic displacement parameters and H atoms were placed at calculated positions and 
refined using a riding model. One of the hexyl chains in 2 is disordered, and the terminal CH2Br 
unit was refined over three orientations with site occupancies of 0.40, 0.40 and 0.20. Similarity 
restraints were applied to the bond distances and to the displacement parameters. For 3, one of the 
Br atoms appears to be disordered and was included in two positions with refined site occupancies 
0.81(1):0.19(1). Corresponding disorder of the neighbouring CH2 group could not be resolved, so 
18 
 
one of the Br positions lies ca 2.3 Å from the CH2 group. Comparable results were obtained from 
full data collections for two crystals within the batch. In 4, both independent bromohexyl chains are 
modelled as disordered over two orientations, one with site occupancies 0.50:0.50 and one with 
0.70:0.30. Similarity restraints were applied to the bond distances and to the displacement 
parameters. In 5, the bromohexyl chain is modelled over two orientations with site occupancies 
0.50:0.50, and the perchlorate anion is also modelled as disordered. The H atoms of the coordinated 
water molecules were visible in difference Fourier maps and their positions were refined with 
restrained O–H distances. 
 
Conclusions 
 
The X-ray structures of several M(II) complexes of 2-(2H-tetrazol-5-yl)pyridine derivatives, 
containing a 6-bromohexyl pendant arm at either the 1-N (L2) or 2-N (L3) position of the tetrazole 
ring, have been studied. In all cases, the 5-(2-pyridyl)tetrazole ligand coordinates in a bidentate 
fashion through the pyridine nitrogen atom and the 1-N nitrogen of the tetrazole ring to form a five-
membered chelate ring with the metal ion. The coordination geometries in the two Cu(II) 
complexes (1 and 2) are slightly distorted square-pyramidal, due mainly to the formation of a 
dimeric Cu2Cl2 core. The coordination geometry at the metal centres in the other three structures (3, 
4 and 5) can be described as slightly distorted octahedral, with two 5-(2-pyridyl)tetrazole ligands 
occupying the equatorial plane in all cases. The axial positions are occupied by the two thiocyanate 
anions in the Co(II) complexes, while they are occupied by two water molecules in the case of the 
Fe(II) complex. The biological studies of these complexes and complexes involving other first row 
transition metal ions will be published in a separate paper.
17
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Appendix A. Supplementary data 
 
Electronic Supplementary Information (ESI) available: packing diagrams for the crystal structures 
of 1-5. CCDC <827225, 759312, 827226, 759313 and 759314> contains the supplementary 
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crystallographic data for <1-5>. These data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic Data 
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; or e-mail: 
deposit@ccdc.cam.ac.uk. 
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